BrightSpec and Cornes Technologies Conclude Demo and Symposium in Japan

Charlottesville, VA—Jan 15, 2018— BrightSpec announced today the successful conclusion of a demonstration of the BrightSpec MRR Discovery series W-band spectrometer in Japan, and a symposium on the molecular rotational resonance (MRR) technique for advanced chemical analysis.

The demonstration instrument was hosted in a research laboratory at Sophia University in Tokyo, where it was used to conduct a series of new experiments, the results of which are expected to be presented at a scientific conference in Japan later this year.  As part of the demonstration, the BrightSpec instrument was featured in a molecular spectroscopy symposium held December 25th in Tokyo.   Japan has a long history of scholarly research and major contributions in the field of high resolution spectroscopy and in particular, in the millimeter- and microwave pure rotational spectroscopy research that underlies MRR.

As part of the demonstration, Cornes Technologies of Japan, the exclusive distributor of  BrightSpec products and services in Japan, engaged Daniel Zaleski, PhD to guide the site installation of the instrument and to give a talk on new measurement modes in MRR spectroscopy, including the patented 3Wave chiral analysis for chiral analysis discovered at Harvard University, and multiplexed cavity and chiral tagging approach, discovered at the University of Virginia.  Dr. Zaleski currently conducts post-doctoral research in MRR, after completing his doctoral work at UVA.

About BrightSpec, Inc.

BrightSpec is the first company to offer commercially available molecular rotational resonance (MRR) spectrometers for identification, quantification and structure analysis of complex chemical mixtures.  The MRR technique arose from advances made in astrochemistry and in particular, from the chirped pulse, Fourier-transform (CPFT) discoveries made at the University of Virginia.   Commercial applications are in R&D, pharmaceuticals, fine chemicals, food, and advanced manufacturing sectors.  BrightSpec received research funding from the US ARMY, the National Science Foundation, and the Virginia BioHealth Research Corporation. For more information, please contact Justin Neill (CTO) or Bob Lloyd (CEO) at 434-202-2391, or visit


Erratum: in the original post, the dateline was 2017.